You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 11, September 17, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Consensus Statement
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Issues in Umbilical Cord Blood Banking

Jeremy Sugarman, MD, MPH, MA; Valerie Kaalund, PhD; Eric Kodish, MD; Mary Faith Marshall, PhD; Emily G. Reisner, PhD; Benjamin S. Wilfond, MD; Paul Root Wolpe, PhD

JAMA. 1997;278(11):938-943.


Abstract

Objective.
—Banking umbilical cord blood (UCB) to be used as a source of stem cells for transplantation is associated with a set of ethical issues. An examination of these issues is needed to inform public policy and to raise the awareness of prospective parents, clinicians, and investigators.

Participants.
—Individuals with expertise in anthropology, blood banking, bone marrow transplantation, ethics, law, obstetrics, pediatrics, and the social sciences were invited to join the Working Group on Ethical Issues in Umbilical Cord Blood Banking.

Evidence.
—Members were assigned topics to present to the Working Group. Following independent reviews, background materials were sent to the Working Group.

Consensus Process.
—Individual presentations of topics at a 2-day meeting were followed by extensive group discussions in which consensus emerged. A writing committee then drafted a document that was circulated to the entire Working Group. After 3 rounds of comments over several months, all but 1 member of the Working Group agreed with the presentation of our conclusions.

Conclusions.
—(1) Umbilical cord blood technology is promising although it has several investigational aspects; (2) during this investigational phase, secure linkage should be maintained of stored UCB to the identity of the donor; (3) UCB banking for autologous use is associated with even greater uncertainty than banking for allogeneic use; (4) marketing practices for UCB banking in the private sector need close attention; (5) more data are needed to ensure that recruitment for banking and use of UCB are equitable; and (6) the process of obtaining informed consent for collection of UCB should begin before labor and delivery.



Author Affiliations

and the Working Group on Ethical Issues in Umbilical Cord Blood Banking

From the Division of General Internal Medicine, Center for the Study of Aging and Human Development, Center for Health Policy Research and Education, Duke University (Dr Sugarman) and HLA Laboratory, Duke University Medical Center (Dr Reisner), Durham, NC; African and Afro-American Studies, University of North Carolina, Chapel Hill (Dr Kaalund); Center for Biomedical Ethics, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Kodish); Program in Bioethics, Medical University of South Carolina, Charleston (Dr Marshall); Department of Pediatrics, University of Arizona, Tucson (Dr Wilfond); and the Center for Bioethics, University of Pennsylvania, Philadelphia (Dr Wolpe).


Footnotes

The views of Liana Harvath, PhD, of the Working Group on Ethical Issues in Umbilical Cord Blood Banking represent scientific opinion and should not be construed as opinion or policy of the US Food and Drug Administration.

A complete list of participants in the Working Group on Ethical Issues in Umbilical Cord Blood Banking appears at the end of this article.

Reprints: Jeremy Sugarman, MD, MPH, MA, Division of General Internal Medicine, Box 3040, Duke University Medical Center, Durham, NC 27710.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Private Cord Blood Banking: Experiences and Views of Pediatric Hematopoietic Cell Transplantation Physicians
Thornley et al.
Pediatrics 2009;123:1011-1017.
ABSTRACT | FULL TEXT  

First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation
Fraser et al.
Blood 2005;106:4377-4380.
ABSTRACT | FULL TEXT  

New trends in umbilical cord blood transplantation
Ballen
Blood 2005;105:3786-3792.
ABSTRACT | FULL TEXT  

Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing
Gollust et al.
JAMA 2002;288:1762-1767.
ABSTRACT | FULL TEXT  

Ethics in the laboratory examination of patients
Nyrhinen and Leino-Kilpi
J. Med. Ethics 2000;26:54-60.
ABSTRACT | FULL TEXT  

Cord Blood Banking for Potential Future Transplantation: Subject Review
Work Group on Cord Blood Banking
Pediatrics 1999;104:116-118.
ABSTRACT | FULL TEXT  

Waste and Longing -- The Legal Status of Placental-Blood Banking
Annas
NEJM 1999;340:1521-1524.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.